Taken together, these data indicated an important role for PLAC8/NOX4 signalling in protecting CB-ECFCs against hypoxia-induced angiogenic dysfunction, thereby highlighting this pathway as a potential target for increasing therapeutic efficacy within the ischaemic cardiovascular disease microenvironment. The gene discussed is NOX4; the disease is cardiovascular disorder.